Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab vs Cisplatin with Radiotherapy in Head and Neck Cancer
NCT00820248Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Dec 2008
- Primary completion
- May 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of panitumumab in head and neck squamous cell carcinoma (HNSCC), sponsored by Canadian Cancer Trials Group. Started Dec 2008; status: completed.
02
Drugs
panitumumab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00820248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00820248.